Effect of CREON on Exocrine Pancreatic Insufficiency (EPI) Symptoms
- Registration Number
- NCT04949828
- Lead Sponsor
- AbbVie
- Brief Summary
Exocrine Pancreatic Insufficiency (EPI) is a condition where pancreatic enzyme quantity or activity is reduced below threshold needed for normal digestion. Symptoms include bloating, flatulence, diarrhea and steatorrhea. This is an observational study assessing for effect of CREON on symptoms of EPI in participants with EPI due to chronic pancreatitis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 63
- Medical history of chronic pancreatitis (CP).
- Diagnosis of Exocrine Pancreatic Insufficiency (EPI).
--History of cystic fibrosis, pancreatic cancer, pancreatic surgery, gastric bypass surgery, extensive bowel surgery, inflammatory bowel disease, celiac disease, irritable bowel syndrome
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Participants on CREON CREON -
- Primary Outcome Measures
Name Time Method Change in Score of EPI Symptoms Domain Using an EPI Patient-Reported Outcomes Questionnaire Up to 1 month
- Secondary Outcome Measures
Name Time Method Change in T-scores for Patient-Reported Outcomes Measurement and Information System(PROMIS) Questionnaires for Anxiety, Depression, and Fatigue Up to 1 month
Trial Locations
- Locations (6)
John Hopkins University /ID# 227061
🇺🇸Baltimore, Maryland, United States
Baylor College of Medicine - Baylor Medical Center /ID# 227067
🇺🇸Houston, Texas, United States
NYU Langone Health /ID# 230818
🇺🇸New York, New York, United States
Stanford University School of Med /ID# 229530
🇺🇸Stanford, California, United States
The Ohio State University Wexner Medical Center /ID# 227844
🇺🇸Columbus, Ohio, United States
University of Florida - Archer /ID# 227057
🇺🇸Gainesville, Florida, United States